Whitepaper - ADCs 2026 WeChat - A Dual-Protective Strategy for Light-Sensitive ADCs - Stevanato Group
Stevanato Group | Pharma & Biotech Integrated Solutions - Stevanato Group > Whitepaper - ADCs 2026 WeChat - A Dual-Protective Strategy for Light-Sensitive ADCs - Stevanato Group
page-wrapper

Low Delamination Propensity and Amber Light Shielding

Discover more on amber glass container applications for Antibody Drug Conjugates (ADCs).

Download the White Paper